General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Bristol Meyers Squib(MODEST), Rocket Pharmaceuticals(MODEST), viz-AI(MODEST), Radcliffe Group(MODEST), WebMD(MODEST), Medscape(MODEST), Lexicon(SIGNIFICANT), Cytokinetics(SIGNIFICANT), Sanofi-Aventis(MODEST) OTHER FINANCIAL BENEFIT: Biomarin(SIGNIFICANT), Bristol-Myers Squibb Company (SIGNIFICANT), Cytokinetics(SIGNIFICANT), Pfizer Inc(SIGNIFICANT)

View Full Disclosure